In 2020, Marc A. Cohen earned $69.50K in total compensation at C4 Therapeutics. Most recently acquired 657 shares in Jan 2022. Currently holds stock worth $6.64M.
Compensation History
Annual executive compensation data for Marc A. Cohen, including salary, bonuses, and stock awards.
Year
2020
Total Compensation
$69.50K
Salary
$0.00
Bonus
$0.00
Other
$69.50K
Salary
$0.00Board Justification
The compensation philosophy aligns with company performance and aims to attract and retain qualified individuals.
Bonus
$0.00Board Justification
Marc A. Cohen did not receive any cash compensation in connection with his service as our interim Chief Executive Officer during 2020.
Other Compensation
$69.50KBoard Justification
This amount represents cash fees paid to Mr. Cohen for his service as a director.
Restricted Stock
Board Justification
Mr. Cohen was granted a stock option to purchase 725,002 shares of our common stock in recognition of his past and future service as our Executive Chairman and interim Chief Executive Officer during 2020, 12.5% of which award vested on April 1, 2021 and the balance of which award vests in 14 equal quarterly installments thereafter.
Performance Metrics
N/A
Marc A. Cohen
Ex-CEO of C4 Therapeutics
Sector of Economy
Healthcare
CEO of C4 Therapeutics for
0 years 0 months (Oct 2020 - Oct 2020)
Previous Experience
Unknown
Other C4 Therapeutics CEOs
Holdings
Track Marc A. Cohen's stock holdings and portfolio value over time.
Insider Trading
Marc A. Cohen's recent stock transactions, purchases, and sales filed with the SEC.
$20.75K
CCCC at $31.58/share
Jan 4, 2022
Received
$20.74K
CCCC at $44.99/share
Oct 4, 2021
Received
$20.73K
CCCC at $39.72/share
Jul 2, 2021
Received
$20.74K
CCCC at $37.51/share
Apr 5, 2021
Received
$95.57K
CCCC at $19.00/share
Oct 6, 2020
Purchase
Rivals
Compare Marc A. Cohen with competitor CEOs and industry peers.